These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37639776)

  • 1. Pediatric myasthenia gravis with a combination of AChR and RyR is associated with an earlier onset and lower CSR rate: A cohort study in southwest China.
    Liu J; Ma J; Hong S; Jiang L; Li T
    Eur J Paediatr Neurol; 2023 Nov; 47():1-5. PubMed ID: 37639776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis.
    Shelton GD; Skeie GO; Kass PH; Aarli JA
    Vet Immunol Immunopathol; 2001 Jan; 78(1):97-105. PubMed ID: 11182151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.
    Romi F; Skeie GO; Aarli JA; Gilhus NE
    Arch Neurol; 2000 Nov; 57(11):1596-600. PubMed ID: 11074791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle autoantibodies in subgroups of myasthenia gravis patients.
    Romi F; Skeie GO; Aarli JA; Gilhus NE
    J Neurol; 2000 May; 247(5):369-75. PubMed ID: 10896269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.
    Mygland A; Vincent A; Newsom-Davis J; Kaminski H; Zorzato F; Agius M; Gilhus NE; Aarli JA
    Arch Neurol; 2000 Apr; 57(4):527-31. PubMed ID: 10768628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies in acquired myasthenia gravis: Clinical phenotype and immunological correlation.
    Nagappa M; Mahadevan A; Gangadhar Y; Patil SA; Bokolia S; Bindu PS; Sinha S; Taly AB
    Acta Neurol Scand; 2019 May; 139(5):428-437. PubMed ID: 30693486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules.
    Romi F; Bø L; Skeie GO; Myking A; Aarli JA; Gilhus NE
    J Neuroimmunol; 2002 Jul; 128(1-2):82-9. PubMed ID: 12098514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Titin and ryanodine receptor antibodies in myasthenia gravis.
    Skeie GO; Aarli JA; Gilhus NE
    Acta Neurol Scand Suppl; 2006; 183():19-23. PubMed ID: 16637922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis.
    Romi F; Gilhus NE; Varhaug JE; Myking A; Skeie GO; Aarli JA
    Eur J Neurol; 2002 Jan; 9(1):55-61. PubMed ID: 11784377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypes.
    Skeie GO; Pandey JP; Aarli JA; Gilhus NE
    Autoimmunity; 1997; 26(2):111-6. PubMed ID: 9546812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study.
    Romi F; Gilhus NE; Varhaug JE; Myking A; Aarli JA
    Eur J Neurol; 2003 Nov; 10(6):701-6. PubMed ID: 14641516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patients.
    Hong Y; Li HF; Skeie GO; Romi F; Hao HJ; Zhang X; Gao X; Owe JF; Gilhus NE
    J Neuroimmunol; 2016 Sep; 298():51-7. PubMed ID: 27609275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report: Telitacicept in severe myasthenia gravis: a case study with multiple autoantibodies.
    Guo Q; Huang Y; Wang F; Fang L
    Front Immunol; 2023; 14():1270011. PubMed ID: 38124751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic myasthenia gravis: immunological and clinical aspects.
    Skeie GO; Romi F
    Eur J Neurol; 2008 Oct; 15(10):1029-33. PubMed ID: 18717725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis.
    Wang R; Li J; Wang M; Hao H; Chen X; Li R; Zhu X
    Br J Dermatol; 2015 Apr; 172(4):968-75. PubMed ID: 25388377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis. A study of IgG subclasses and clinical correlations.
    Romi F; Skeie GO; Vedeler C; Aarli JA; Zorzato F; Gilhus NE
    J Neuroimmunol; 2000 Nov; 111(1-2):169-76. PubMed ID: 11063835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.
    Mygland A; Aarli JA; Matre R; Gilhus NE
    J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):843-6. PubMed ID: 8021674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Distribution characteristics and correlation analysis of antibody detection value in myasthenia gravis].
    Liu YL; Zheng YM; Luo JJ; Zhang W; Gao F; Yuan Y; Hao HJ
    Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(41):3221-3226. PubMed ID: 31694116
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathogenesis of myositis and myasthenia associated with titin and ryanodine receptor antibodies.
    Skeie GO; Romi F; Aarli JA; Bentsen PT; Gilhus NE
    Ann N Y Acad Sci; 2003 Sep; 998():343-50. PubMed ID: 14592894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features.
    Romi F; Aarli JA; Gilhus NE
    Eur J Neurol; 2007 Jun; 14(6):617-20. PubMed ID: 17539937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.